{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:10:08Z","timestamp":1792001408197,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF18OC0034612"],"award-info":[{"award-number":["NNF18OC0034612"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.radonc.2023.109958","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T15:04:23Z","timestamp":1697900663000},"page":"109958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Considerations for study design in the DAHANCA 35 trial of protons versus photons for head and neck cancer"],"prefix":"10.1016","volume":"190","author":[{"given":"J.","family":"Friborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sams\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Maare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sibolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.I.S.","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Skyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Smulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.R.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109958_b0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.radonc.2021.04.011","article-title":"Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer","volume":"160","author":"van der Laan","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0010","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1200\/JCO.2015.61.2994","article-title":"Advances in radiotherapy for head and neck cancer","volume":"33","author":"Gregoire","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0015","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijrobp.2014.02.029","article-title":"Proton radiation therapy for head and neck cancer: a review of the clinical experience to date","volume":"89","author":"Holliday","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109958_b0020","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ijrobp.2016.02.044","article-title":"Intensity modulated proton therapy versus intensity modulated photon radiation therapy for oropharyngeal cancer: First comparative results of patient-reported outcomes","volume":"95","author":"Sio","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109958_b0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2016.05.022","article-title":"Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis","volume":"120","author":"Blanchard","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0030","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijrobp.2016.02.021","article-title":"Clinical outcomes and patterns of disease recurrence after intensity modulated proton therapy for oropharyngeal squamous carcinoma","volume":"95","author":"Gunn","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109958_b0035","doi-asserted-by":"crossref","unstructured":"Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Physics in medicine and biology. 2014 Nov 21;59:R419-72.","DOI":"10.1088\/0031-9155\/59\/22\/R419"},{"key":"10.1016\/j.radonc.2023.109958_b0040","doi-asserted-by":"crossref","unstructured":"Kraan AC, van de Water S, Teguh DN, Al-Mamgani A, Madden T, Kooy HM, et al. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors. Int J Radiat Oncol Biol Phys. 2013 Dec 01;87:888-96.","DOI":"10.1016\/j.ijrobp.2013.09.014"},{"key":"10.1016\/j.radonc.2023.109958_b0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.radonc.2020.07.056","article-title":"First experience with model-based selection of head and neck cancer patients for proton therapy","volume":"151","author":"Tambas","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0050","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.semradonc.2017.12.002","article-title":"Comparing intensity-modulated proton therapy with intensity-modulated photon therapy for oropharyngeal cancer: The journey from clinical trial concept to activation","volume":"28","author":"Frank","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejca.2017.03.006","article-title":"Quality of life in survivors of oropharyngeal cancer: A systematic review and meta-analysis of 1366 patients","volume":"78","author":"H\u00f8xbroe Michaelsen","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2023.109958_b0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.radonc.2008.12.017","article-title":"A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer","volume":"90","author":"Langendijk","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0065","doi-asserted-by":"crossref","unstructured":"Langendijk JA, Hoebers FJP, de Jong MA, Doornaert P, Terhaard CHJ, Steenbakkers R, et al. National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer. Int J Part Ther. 2021 Summer;8:354-65.","DOI":"10.14338\/IJPT-20-00089.1"},{"key":"10.1016\/j.radonc.2023.109958_b0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2011.08.009","article-title":"Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study","volume":"105","author":"Christianen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.radonc.2012.03.004","article-title":"NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors","volume":"105","author":"Beetz","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.radonc.2016.08.022","article-title":"Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort","volume":"121","author":"Blanchard","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.radonc.2021.01.024","article-title":"Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment","volume":"157","author":"Van den Bosch","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0090","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/0284186X.2019.1654129","article-title":"NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy","volume":"58","author":"Hansen","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.radonc.2007.04.001","article-title":"Tumor progression in waiting time for radiotherapy in head and neck cancer","volume":"84","author":"Jensen","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0100","doi-asserted-by":"crossref","unstructured":"Lyhne NM, Christensen A, Alanin MC, Bruun MT, Jung TH, Bruhn MA, et al. Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002. European journal of cancer (Oxford, England : 1990). 2013 May;49:1627-33.","DOI":"10.1016\/j.ejca.2012.11.034"},{"key":"10.1016\/j.radonc.2023.109958_b0105","doi-asserted-by":"crossref","unstructured":"Hansen CR, Jensen K, Smulders B, Holm AIS, Samsoe E, Nielsen MS, et al. Evaluation of decentralised model-based selection of head and neck cancer patients for a proton treatment study. DAHANCA 35. Radiother Oncol. 2023 Jul 20:109812.","DOI":"10.1016\/j.radonc.2023.109812"},{"key":"10.1016\/j.radonc.2023.109958_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2020.07.037","article-title":"The danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines","author":"Jensen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gregoire","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109958_b0125","doi-asserted-by":"crossref","unstructured":"Gregoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2014 Jan;110:172-81.","DOI":"10.1016\/j.radonc.2013.10.010"},{"key":"10.1016\/j.radonc.2023.109958_b0130","doi-asserted-by":"crossref","unstructured":"Nowicka-Matus K. Acute toxicities in proton therapy for head and neck cancer \u2013 a matched analysis of the DAHANCA 35 pilot study. Submitted. 2022.","DOI":"10.1016\/S0167-8140(22)02465-3"},{"key":"10.1016\/j.radonc.2023.109958_b0135","doi-asserted-by":"crossref","unstructured":"Lee A, Kang J, Yu Y, McBride S, Riaz N, Cohen M, et al. Trends and Disparities of Proton Therapy Use among Patients with Head and Neck Cancer: Analysis from the National Cancer Database (2005-14). Int J Part Ther. 2019 Spring;5:1-10.","DOI":"10.14338\/IJPT-19-00051.1"},{"key":"10.1016\/j.radonc.2023.109958_b0140","doi-asserted-by":"crossref","first-page":"e228970","DOI":"10.1001\/jamanetworkopen.2022.8970","article-title":"Association of race with receipt of proton beam therapy for patients with newly diagnosed cancer in the US, 2004\u20132018","volume":"5","author":"Nogueira","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.radonc.2023.109958_b0145","doi-asserted-by":"crossref","unstructured":"Hernandez M, Lee JJ, Yeap BY, Ye R, Foote RL, Busse P, et al. The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance Denial. Adv Radiat Oncol. 2021 Mar-Apr;6:100635.","DOI":"10.1016\/j.adro.2020.100635"},{"key":"10.1016\/j.radonc.2023.109958_b0150","first-page":"147","article-title":"TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer","volume":"38","author":"Thomson","year":"2023","journal-title":"Clin Transl Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023898528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023898528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T09:10:25Z","timestamp":1734253825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023898528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":30,"alternative-id":["S0167814023898528"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109958","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considerations for study design in the DAHANCA 35 trial of protons versus photons for head and neck cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109958"}}